Miostat Side Effects

Generic name: carbachol ophthalmic

Medically reviewed by Drugs.com. Last updated on Apr 21, 2023.

Note: This document contains side effect information about carbachol ophthalmic. Some dosage forms listed on this page may not apply to the brand name Miostat.

Applies to carbachol ophthalmic: ophthalmic intraocular injection, ophthalmic topical solution.

Side effects include:

Topical solution: Ocular irritation (burning or discomfort), lacrimation, temporal or periorbital headache, painful ciliary or accommodative spasm, blurred vision or myopia, conjunctival vascular congestion, poor vision in dim light.

For Healthcare Professionals

Applies to carbachol ophthalmic: compounding powder, intraocular solution, ophthalmic solution.

General

The most commonly reported side effects were headache and increased intraocular pressure.^[Ref]

Ocular

Uncommon (0.1% to 1%): Increased intraocular pressure

Frequency not reported: Corneal clouding, persistent bullous keratopathy, retinal detachment/postoperative iritis following cataract extraction, anterior chamber inflammation, corneal edema, eye inflammation, visual impairment, corneal degeneration, miosis, blurred vision, eye pain, ocular hyperemia^[Ref]

Cardiovascular

Frequency not reported: Flushing^[Ref]

Dermatologic

Frequency not reported: Sweating^[Ref]

Gastrointestinal

Frequency not reported: Epigastric distress, abdominal cramps, vomiting^[Ref]

Genitourinary

Frequency not reported: Tightness in urinary bladder^[Ref]

Nervous system

Uncommon (0.1% to 1%): Headache^[Ref]

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.

Medical Disclaimer